Axsome Therapeutics Newsroom

Mizuho Securities Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Announces Target Price $124

Moomoo News14:31 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), Zymeworks (ZYME) and Axsome Therapeutics (AXSM)

TipRanksDec 16 01:33 ET

Morgan Stanley Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $125

Moomoo NewsDec 14 09:32 ET

Axsome Therapeutics Analyst Ratings

BenzingaDec 12 11:55 ET

Mizuho Securities Maintains Axsome Therapeutics(AXSM.US) With Buy Rating

Moomoo NewsDec 10 02:32 ET

Positive Outlook for Axsome Therapeutics: Buy Rating Backed by Promising AXS-05 Prospects

TipRanksDec 10 01:39 ET

Morgan Stanley Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $125

Moomoo NewsDec 7 11:31 ET

Axsome Therapeutics: Promising Growth Trajectory Justifies Buy Rating Amidst Auvelity's Commercial Success

TipRanksDec 7 10:36 ET

Morgan Stanley Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $125

Moomoo NewsNov 30 08:32 ET

Ladenburg Thalmann Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $175

Moomoo NewsNov 28 05:34 ET

Analysts Are Bullish on Top Healthcare Stocks: Axsome Therapeutics (AXSM), Madrigal Pharmaceuticals (MDGL)

TipRanksNov 28 05:02 ET

Axsome Therapeutics (AXSM) Gets a Buy From RBC Capital

TipRanksNov 27 20:49 ET

Axsome Therapeutics Analyst Ratings

BenzingaNov 27 08:11 ET

Truist Financial Maintains Axsome Therapeutics(AXSM.US) With Buy Rating

Moomoo NewsNov 27 07:31 ET

H.C. Wainwright Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $180

Moomoo NewsNov 27 06:32 ET

Mizuho Securities Maintains Axsome Therapeutics(AXSM.US) With Buy Rating

Moomoo NewsNov 27 01:31 ET

Axsome Therapeutics Analyst Ratings

BenzingaNov 25 08:20 ET

H.C. Wainwright Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $180

Moomoo NewsNov 25 07:31 ET

Positive Prescription Trends and Sales Expansion Drive Buy Rating for Axsome Therapeutics

TipRanksNov 25 02:37 ET

Cantor Fitzgerald Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Raises Target Price to $121

Moomoo NewsNov 13 13:31 ET